Company Filing History:
Years Active: 2013-2018
Title: Mark Dexter Wright: Innovator in Dendritic Cell Research
Introduction
Mark Dexter Wright is a notable inventor based in Northcote, Australia. He has made significant contributions to the field of medical research, particularly in the area of dendritic cells. With a total of 2 patents, his work has implications for immunology and therapeutic applications.
Latest Patents
Wright's latest patents focus on the identification of proteins located on the cell surface of dendritic cells or their precursors. One of his key inventions is related to compounds such as antibodies that bind these proteins. These compounds can be utilized to detect and enrich specific subsets of dendritic cells or their precursors. Furthermore, they can target antigens to dendritic cells, modulating both humoral and T cell-mediated immune responses. This innovation also extends to targeting cytotoxic agents to dendritic cells involved in diseased states.
Career Highlights
Mark Dexter Wright is affiliated with the Walter and Eliza Hall Institute of Medical Research, where he continues to advance his research. His work is pivotal in understanding the immune system and developing new therapeutic strategies.
Collaborations
Wright collaborates with esteemed colleagues, including Mireille Hanna Lahoud and Anna Irene Proietto. Their combined expertise enhances the research output and innovation at the institute.
Conclusion
Mark Dexter Wright's contributions to dendritic cell research exemplify the impact of innovative thinking in medical science. His patents and ongoing work continue to pave the way for advancements in immunotherapy and disease treatment.